Allied-Market-Research-mobile

Coming Up With New Logo

Cart
0
Get 20% Free Customization In This Report

Global Biocompatibility Testing Services Market by Type (Material Characterization, Cytotoxicity, Hemocompatibility, Implantation Testing, Intracutaneous Reactivity, Sensitization, Systemic Toxicity, Pyrogenecity, and USP Plastics) - Opportunity Analysis and Industry Forecast, 2017-2023

  • ID: LI 172927
  • Mar 2018
  • NA pages
  • Price: $4028
$2592

Biocompatibility testing services deals with a set of guidelines and testing parameters used for evaluation of medical device or any compounds safety before coming to the market. The testing services ranges from initial screening of new materials to product release testing and non-clinical or pre-market safety evaluations.

Rise in R&D procedures regarding biocompatibility testing services, adoption of advanced testing services, and increase in government funding for healthcare services drive the market growth. Moreover, medical devices and materials need to meet the biocompatibility requirements so that they are compatible with other materials or body tissues. This requirement drives the growth of the biocompatibility testing services market. However, difficulties to obtain information this information restrain the market growth. These tests are time-consuming and expensive, thus restraining the growth of the market. Besides, the introduction of new testing procedures and growth opportunities in the emerging economies of Asia-Pacific and LAMEA are expected to provide numerous opportunities for the market growth during the forecast period.

Biocompatibility testing services market is segmented on the basis of type and geography. On the basis of type, it is segmented into material characterization, cytotoxicity, hemocompatibility, implantation testing, intracutaneous reactivity, sensitization, systemic toxicity, pyrogenecity, and USP plastics. By geography the market is analyzed across North America (U.S., Canada, and Mexico), Europe (Germany, UK, France, Italy, Spain, and rest of Europe), Asia-Pacific (Japan, China, India, Australia, South Korea, and rest of Asia-Pacific), and LAMEA (Brazil, Saudi Arabia, South Africa, and rest of LAMEA).

Key players profiled in the report include Wickham Laboratories, North American Science Associates Inc., GLR Laboratories Pvt Ltd., Accuprec Research Labs Pvt. Ltd., Nelson Laboratories, Inc., Toxikon, Inc., Pacific BioLabs, BioComp Laboratories, Inc., Morulaa HealthTech Pvt. Ltd., and Geneva Laboratories.

Key Benefits

  • The study provides an in-depth analysis of the market with current trends and future estimations to elucidate the imminent investment pockets.
  • It offers a quantitative analysis from 2016 to 2023 which is expected to enable the stakeholders to capitalize on prevailing market opportunities.
  • Extensive analysis by type elucidates various types of testing procedures used for biocompatibility checking.
  • Comprehensive analysis of all geographical regions is provided, which helps determine the prevailing opportunities.
  • Key players are profiled and their strategies are analyzed thoroughly, which helps in understanding competitive outlook of the global market.

Global Biocompatibility Testing Services Market Key Segments:

By Type

  • Material/Chemical Characterization
  • Cytotoxicity
    • Agarose Overlay
    • MEM Elution
    • Direct Contact
    • MTT Assay
  • Hemocompatibility
    • JP Hemolysis Test
    • ASTM Hemolysis
  • Implantation Testing
    • Intramuscular Implantation
    • Subcutaneous Implantation
  • Irritation / Intracutaneous Reactivity
    • Intracutaneous Reactivity
    • Mucosal Irritation
    • Ocular Irritation
    • Intraocular Irritation
    • Dermal Irritation
  • Sensitization
    • Closed Patch Dermal Irritation
    • Maximization Test
  • Systemic Toxicity
  • Pyrogenicity
    • Pyrogen Test
    • Rabbit Pyrogen Test
    • JP Rabbit Pyrogen Test
  • USP Plastics (USP Class VI)
    • USP I-VI
    • USP Systemic Injection Test
    • USP Intracutaneous Test
    • USP Implant Test
    • USP Safety Test

By Region

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • France
    • Italy
    • Spain
    • Rest of Europe
  • Asia-Pacific
    • Japan
    • China
    • India
    • Australia
    • South Korea
    • Rest of Asia-Pacific
  • LAMEA
    • Brazil
    • South Africa
    • Saudi Arabia
    • Rest of LAMEA
 

Chapter 1 INTRODUCTION

1.1. REPORT DESCRIPTION
1.2. KEY BENEFITS
1.3. KEY MARKET SEGMENTS
1.4. RESEARCH METHODOLOGY

1.4.1. Secondary research
1.4.2. Primary research
1.4.3. Analyst tools & models

Chapter 2 EXECUTIVE SUMMARY

2.1. CXO PERSPECTIVE

Chapter 3 MARKET OVERVIEW

3.1. MARKET DEFINITION AND SCOPE
3.2. KEY FINDINGS

3.2.1. Top investment pockets
3.2.2. Top winning strategies

3.3. MARKET SHARE ANALYSIS, 2016
3.4. PORTERS FIVE FORCES ANALYSIS
3.5. MARKET DYNAMICS

3.5.1. Drivers
3.5.2. Restraints
3.5.3. Opportunities

Chapter 4 BIOCOMPATIBILITY TESTING SERVICES MARKET, BY TYPE

4.1. OVERVIEW

4.1.1. Market size and forecast

4.2. MATERIAL/CHEMICAL CHARACTERIZATION

4.2.1. Key market trends
4.2.2. Key growth factors and opportunities
4.2.3. Market size and forecast

4.3. CYTOTOXICITY

4.3.1. Key market trends
4.3.2. Key growth factors and opportunities
4.3.3. Market size and forecast
4.3.4. Agarose overlay

4.3.4.1. Market size and forecast

4.3.5. MEM elution

4.3.5.1. Market size and forecast

4.3.6. Direct contact

4.3.6.1. Market size and forecast

4.3.7. MIT assay

4.3.7.1. Market size and forecast

4.4. HEMOCOMPATIBILITY

4.4.1. Key market trends
4.4.2. Key growth factors and opportunities
4.4.3. Market size and forecast
4.4.4. JP hemolysis test

4.4.4.1. Market size and forecast

4.4.5. ASTM hemolysis

4.4.5.1. Market size and forecast

4.5. IMPLANTATION TESTING

4.5.1. Key market trends
4.5.2. Key growth factors and opportunities
4.5.3. Market size and forecast
4.5.4. Intamuscular implantation

4.5.4.1. Market size and forecast

4.5.5. Subcutaneous implantation

4.5.5.1. Market size and forecast

4.6. IRRITATION/ INTRACUTANEOUS REACTIVITY

4.6.1. Key market trends
4.6.2. Key growth factors and opportunities
4.6.3. Market size and forecast
4.6.4. Intracutaneous reactivity

4.6.4.1. Market size and forecast

4.6.5. Mucosal irritation

4.6.5.1. Market size and forecast

4.6.6. Ocular irritation

4.6.6.1. Market size and forecast

4.6.7. Intraocular irritation

4.6.7.1. Market size and forecast

4.6.8. Dermal irritation

4.6.8.1. Market size and forecast

4.7. SENSITIZATION

4.7.1. Key market trends
4.7.2. Key growth factors and opportunities
4.7.3. Market size and forecast
4.7.4. Closed patch dermal irritation

4.7.4.1. Market size and forecast

4.7.5. Maximization test

4.7.5.1. Market size and forecast

4.8. SYSTEMIC TOXICITY

4.8.1. Key market trends
4.8.2. Key growth factors and opportunities
4.8.3. Market size and forecast

4.9. PYROGENECITY

4.9.1. Key market trends
4.9.2. Key growth factors and opportunities
4.9.3. Market size and forecast
4.9.4. Pyrogen test

4.9.4.1. Market size and forecast

4.9.5. Rabbit pyrogen test

4.9.5.1. Market size and forecast

4.9.6. JP rabbit pyrogen test

4.9.6.1. Market size and forecast

4.10. USP PLASTICS

4.10.1. Key market trends
4.10.2. Key growth factors and opportunities
4.10.3. Market size and forecast
4.10.4. USP I-VI

4.10.4.1. Market size and forecast

4.10.5. USP systemic injection test

4.10.5.1. Market size and forecast

4.10.6. USP intracutaneous test

4.10.6.1. Market size and forecast

4.10.7. USP implant test

4.10.7.1. Market size and forecast

4.10.8. USP safety test

4.10.8.1. Market size and forecast

Chapter 5 BIOCOMPATIBILITY TESTING SERVICES MARKET, BY REGION

5.1. OVERVIEW
5.2. NORTH AMERICA

5.2.1. Key market trends
5.2.2. Key growth factors and opportunities
5.2.3. Market size and forecast

5.2.3.1. U.S. market size and forecast
5.2.3.2. Canada market size and forecast
5.2.3.3. Mexico market size and forecast

5.2.4. North America biocompatibility testing services market, by type

5.3. EUROPE

5.3.1. Key market trends
5.3.2. Key growth factors and opportunities
5.3.3. Market size and forecast

5.3.3.1. Germany market size and forecast
5.3.3.2. France market size and forecast
5.3.3.3. UK market size and forecast
5.3.3.4. Italy market size and forecast
5.3.3.5. Spain market size and forecast
5.3.3.6. Rest of Europe market size and forecast

5.3.4. Europe biocompatibility testing services market, by type

5.4. ASIA-PACIFIC

5.4.1. Key market trends
5.4.2. Key growth factors and opportunities
5.4.3. Market size and forecast

5.4.3.1. Japan market size and forecast
5.4.3.2. China market size and forecast
5.4.3.3. Australia market size and forecast
5.4.3.4. India market size and forecast
5.4.3.5. South Korea market size and forecast
5.4.3.6. Rest of Asia-Pacific market size and forecast

5.4.4. Asia-Pacific biocompatibility testing services market, by type

5.5. LAMEA

5.5.1. Key market trends
5.5.2. Key growth factors and opportunities
5.5.3. Market size and forecast

5.5.3.1. Brazil market size and forecast
5.5.3.2. Saudi Arabia market size and forecast
5.5.3.3. South Africa market size and forecast
5.5.3.4. Rest of LAMEA market size and forecast

5.5.4. LAMEA biocompatibility testing services market, by type

Chapter 6 COMPANY PROFILES

6.1. WICKHAM LABORATORIES

6.1.1. Operating business segments
6.1.2. Business performance
6.1.3. Key strategic moves and developments

6.2. NORTH AMERICAN SCIENCE ASSOCIATES INC.

6.2.1. Operating business segments
6.2.2. Business performance
6.2.3. Key strategic moves and developments

6.3. GLR LABORATORIES PVT LTD.

6.3.1. Operating business segments
6.3.2. Business performance
6.3.3. Key strategic moves and developments

6.4. ACCUPREC RESEARCH LABS PVT. LTD.

6.4.1. Operating business segments
6.4.2. Business performance
6.4.3. Key strategic moves and developments

6.5. NELSON LABORATORIES, INC.

6.5.1. Operating business segments
6.5.2. Business performance
6.5.3. Key strategic moves and developments

6.6. TOXIKON, INC.

6.6.1. Operating business segments
6.6.2. Business performance
6.6.3. Key strategic moves and developments

6.7. PACIFIC BIOLABS

6.7.1. Operating business segments
6.7.2. Business performance
6.7.3. Key strategic moves and developments

6.8. BIOCOMP LABORATORIES, INC.

6.8.1. Operating business segments
6.8.2. Business performance
6.8.3. Key strategic moves and developments

6.9. MORULAA HEALTHTECH PVT. LTD.

6.9.1. Operating business segments
6.9.2. Business performance
6.9.3. Key strategic moves and developments

6.10. GENEVA LABORATORIES

6.10.1. Operating business segments
6.10.2. Business performance
6.10.3. Key strategic moves and developments

 
With collective industry experience of about 200 years of its analysts and experts, Allied Market Research (AMR) encompasses most infallible research methodology for its market intelligence and industry analysis. We do not only engrave the deepest levels of markets but also sneak through its slimmest details for the purpose of our market estimates and forecasts. Our approach helps in building greater market consensus view for size, shape and industry trends within each industry segment. We carefully factor in industry trends and real developments for identifying key growth factors and future course of the market. Our research proceeds are the resultant of high quality data, expert views and analysis and high value independent opinions. Our research process is designed to deliver balanced view of the global markets and allow stakeholders to make informed decisions.

We offer our clients exhaustive research and analysis based on wide variety of factual inputs, which largely include interviews with industry participants, reliable statistics and regional intelligence. Our in-house industry experts play instrumental role in designing analytic tools and models, tailored to the requirements of particular industry segment. These analytical tools and models sanitize the data & statistics and enhance the accuracy of our recommendations and advice. With AMR’s calibrated research process and 360` degree data-evaluation methodology, our clients are assured of receiving:

  • Consistent, valuable, robust and actionable data & analysis that can easily be referenced for strategic business planning
  • Technologically sophisticated and reliable insights through well audited and veracious research methodology
  • Sovereign research proceeds that present a tangible depiction of marketplace


With a strong methodology we are, therefore, confident that our research and analysis are most reliable and guarantees sound business planning.

Secondary research
We refer a broad array of industry sources for our secondary, which typically include; however, not limited to: Company SEC filings, annual reports, company websites, broker & financial reports and investor presentations for competitive scenario and shape of the industry

  • Patent and regulatory databases for understanding of technical & legal developments
  • Scientific and technical writings for product information and related preemptions
  • Regional government and statistical databases for macro analysis
  • Authentic new articles, web-casts and other related releases for market evaluation
  • Internal and external proprietary databases, key market indicators and relevant press releases for market estimates and forecast


Primary research
Our primary research efforts include reaching out participants through mail, tele-conversations, referrals, professional networks and face-to-face interactions. We are also in professional corporate relations with various companies that allow us greater flexibility for reaching out industry participants and commentators for interviews and discussions, fulfilling following functions:

  • Validates and improves the data quality and strengthens research proceeds
  • Further develops analyst team’s market understanding and expertise
  • Supplies authentic information about market size, share, growth and forecasts


Our primary research interview and discussion panels are typically composed of most experienced industry members. These participants include; however, not limited to:

  • Chief executives and VPs of leading corporations specific to industry
  • Product and sales managers or country heads; channel partners and top level distributors; banking, investments and valuation experts Key opinion leaders (KOLs)


Analyst tools and models
AMR has developed set of analyst tools and data models to supplement and expedite the analysis process. Corresponding to markets, where there is significant lack of information and estimates, AMR’s team of experts and analyst develop specific analyst tools and industry models to translate qualitative and quantitative industry indicators into exact industry estimates. These models also allow analysts to examine the prospects and opportunities prevailing in the market to accurately forecast the course of the market.
 

* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.

 

Get More Information About This Report

For any queries about purchasing this report, For any queries, please fill the form below:

Please input the above text in the input box or click refresh

 

HAVE QUESTIONS?
SPEAK WITH ANALYST

 
 

FREQUENTLY ASK
QUESTIONS?

 
 

DID YOU MISS ANYTHING?
DO YOU HAVE SPECIFIC REQUIREMENTS?

 
 
 

PURCHASE OPTIONS

* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.

Reach out to us

Call us on
( U.S. - Canada toll free )
+1-800-792-5285,    Int'l : +1-503-894-6022
Drop us an email at
help@alliedmarketresearch.com

Send Enquiry
 
 

Why Allied Market Research

 

Infallible Methodology

To ensure high level data integrity, accurate analysis and impeccable forecasts

Analyst Support

For complete satisfaction

Customization

On-demand customization of scope of the report to exactly meet your needs

TARGETED MARKET VIEW

Targeted market view to provide pertinent information and save time of readers

 
 

Featured Readings

 
 

Get Fresh content delivered

Get insights on topics that are crucial for your business. Stay abreast of your interest areas.

 
Get Industry Data Alerts